HHS, DOD engage Quantum Leap Research Collaborative in search for effective treatments for the sickest COVID-19 patients
In the race to identify safe and effective therapeutic treatments for the sickest COVID-19 patients, the U.S. Department of Health and Human Services and the Department of Defense are engaging a non-profit research organization, Quantum Leap Research Collaborative of San Francisco, on a phase 2 clinical trial that rapidly screens multiple potential drugs simultaneously. “Through our Operation Warp Speed partnership, we have worked feverishly with private industry to develop and make treatments available to reduce hospitalization, either shortening the length of stay or treating people with ...
Source: oc-breeze.com